Telephone
1.800.884.5367
Address
Suite 215 30 Mansell Court Alpharetta, GA 30076
Description
Visioneering Technologies, Inc. is an eye care company, which engages in the design, manufacture, sale, and distribution of contact lenses. The firm focuses on the treatment of presbyopia in adults and myopia correction in children. The company's flagship product is NaturalVue, which is used in multifocal contact lenses for the treatment of myopia. It operates through the North America and Europe/Asia-Pacific geographic segments. The North America segment includes the firm's current operations in the U.S. and Canada. The Europe/Asia-Pacific segment refers to the operations outside of North America. The company was by Richard A. Griffin founded in 2008 and is headquartered in Alpharetta, GA.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.19 - 0.45
Trade Value (12mth)
AU$1,165.00
1 week
4.44%
1 month
6.82%
YTD
-38.62%
1 year
-29.85%
All time high
55.0357
EPS 3 yr Growth
-94.100%
EBITDA Margin
-78.00%
Operating Cashflow
-$9m
Free Cash Flow Return
-59.60%
ROIC
-58.30%
Interest Coverage
-19.20
Quick Ratio
4.80
Shares on Issue (Fully Dilluted)
0m
HALO Sector
Industrials
Next Company Report Date
21-Feb-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 July 20 |
VTI to Present at SNN Network Virtual Investor Conference
×
VTI to Present at SNN Network Virtual Investor Conference |
31 January 23 |
Appendix 4C and Business Activity Report - Dec-22 Qtr
×
Appendix 4C and Business Activity Report - Dec-22 Qtr |
30 March 23 |
Notification regarding unquoted securities - VTI
×
Notification regarding unquoted securities - VTI |
30 June 22 |
Director Appointment and Retirement
×
Director Appointment and Retirement |
30 June 22 |
Initial Director's Interest Notice - Dr Allan E. Rubenstein
×
Initial Director's Interest Notice - Dr Allan E. Rubenstein |
29 May 20 |
AGM MD Presentation
×
AGM MD Presentation |
29 May 20 |
Results of Annual Meeting
×
Results of Annual Meeting |
29 May 17 |
Company Presentation
×
Company Presentation |
29 March 23 |
Application for quotation of securities - VTI
×
Application for quotation of securities - VTI |
29 March 23 |
Application for quotation of securities - VTI
×
Application for quotation of securities - VTI |
29 March 23 |
Application for quotation of securities - VTI
×
Application for quotation of securities - VTI |
29 March 23 |
Notice given under Section 708A(5)(e) of Corporations Act
×
Notice given under Section 708A(5)(e) of Corporations Act |
29 March 19 |
2018 Annual Report
×
2018 Annual Report |
29 March 18 |
2017 Annual Report
×
2017 Annual Report |
29 January 19 |
Investor Presentation - January 2019
×
Investor Presentation - January 2019 |
29 January 18 |
Advance Notice - 2018 Annual General Meeting
×
Advance Notice - 2018 Annual General Meeting |
29 December 21 |
Notification regarding unquoted securities - VTI
×
Notification regarding unquoted securities - VTI |
29 August 23 |
Appointment of CEO and Executive Director
×
Appointment of CEO and Executive Director |
28 September 20 |
VTI Presents Positive 5-Year Data In Children
×
VTI Presents Positive 5-Year Data In Children |
28 March 19 |
Notice of Annual General Meeting/Proxy/CDI Voting Form
×
Notice of Annual General Meeting/Proxy/CDI Voting Form |
28 February 23 |
Appendix 4E and Annual Financial Statements
×
Appendix 4E and Annual Financial Statements |
27 October 22 |
Results of Special Meeting of Stockholders
×
Results of Special Meeting of Stockholders |
27 July 21 |
Investor Presentation
×
Investor Presentation |
27 July 21 |
VTI to present - Coffee Microcaps Appendix 4C Reporting Wrap
×
VTI to present - Coffee Microcaps Appendix 4C Reporting Wrap |
27 January 22 |
Investor Presentation
×
Investor Presentation |
26 October 23 |
Adjournment of Special Meeting of Stockholders
×
Adjournment of Special Meeting of Stockholders |
26 October 23 |
Extension of Closing Date for Rights Offering
×
Extension of Closing Date for Rights Offering |
26 October 23 |
Appendix 3B
×
Appendix 3B |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.